Nutlin‐3 has a synergistic cytotoxic effect when used in combination with TNF‐related apoptosis‐inducing ligand (TRAIL), bortezomib, and cisplatin to induce p53‐dependent tumor cell apoptosis in NSCLC [31, 33]. Here, TP53 is linked to neoplasm.